Integra Lifesciences share price today

(IART)

Integra Lifesciences share price is $21.8 & ₹1,852.48 as on 21 Dec 2024, 2.30 'hrs' IST

$21.8

▲

0.09

(0.41%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Integra Lifesciences share price in Dollar and Rupees. Guide to invest in Integra Lifesciences from India. Also see the sentimental analysis on Indian investors investing in Integra Lifesciences. Get details on the Indian mutual funds that are investing in Integra Lifesciences. Get Analyst recommendations and forecasts along with all the Integra Lifesciences's financials.

Integra Lifesciences share price movements

Today's Low: $21.31
Today's High: $22.28
$21.80
2.25%
Downside
Day's Volatility :4.33%
Upside
2.13%
52 Weeks Low: $16.81
52 Weeks High: $45.42
$21.80
22.91%
Downside
52 Weeks Volatility :63.0%
Upside
52.0%

Integra Lifesciences Returns

Period	Integra Lifesciences Holdings Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	24.29%	-11.1%	0.0%
6 Months	-26.92%	-6.0%	0.0%
1 Year	-51.11%	2.7%	0.0%
3 Years	-68.02%	0.6%	-19.7%

Integra Lifesciences Key Statistics

in dollars & INR

Previous Close	$21.71
Open	$21.48
Today's High	$22.275
Today's Low	$21.31
Market Capitalization	$1.7B
Today's Volume	$1.2M
52 Week High	$45.42
52 Week Low	$16.805
Revenue TTM	$1.6B
EBITDA	$323.1M
Earnings Per Share (EPS)	$-0.09
Profit Margin	-0.42%
Quarterly Earnings Growth YOY	-0.6%
Return On Equity TTM	-0.42%

How to invest in Integra Lifesciences from India?

It is very easy for Indian residents to invest directly in Integra Lifesciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Integra Lifesciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Integra Lifesciences or IART on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Integra Lifesciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Integra Lifesciences shares which would translate to 0.039 fractional shares of Integra Lifesciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Integra Lifesciences, in just a few clicks!

Returns in Integra Lifesciences for Indian investors in Rupees

Investment Value

₹1,00,000

Integra Lifesciences investment value today

Current value as on today

₹1,53,306

Returns

₹53,306

(+53.31%)

Returns from Integra Lifesciences Stock

₹51,110 (false-51.11%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Integra Lifesciences

-33%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Integra Lifesciences on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -33% less investors are searching Integra Lifesciences in the last 30 days versus the previous period.

Global Institutional Holdings in Integra Lifesciences

BlackRock Inc
14.58%
Vanguard Group Inc
10.04%
Morgan Stanley - Brokerage Accounts
6.81%
Fuller & Thaler Asset Management Inc
5.14%
AllianceBernstein L.P.
3.92%
State Street Corp
3.66%

Analyst Recommendation on Integra Lifesciences

Buy

50%Buy

35%Hold

15%Sell

Based on 20 Wall street analysts offering stock ratings for Integra Lifesciences(by analysts ranked 0 to 5 stars)

Based on 20 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Integra Lifesciences

What analysts predicted

Upside of 19.27%

Current:

$21.80

Target:

$26.00

Insights on Integra Lifesciences

Price Movement
In the last 7 days, IART stock has moved down by -9.3%
Decreasing Revenue
Revenue is down for the last 2 quarters, 418.17M → 380.83M (in $), with an average decrease of 8.9% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -12.40M → -10.69M (in $), with an average increase of 16.0% per quarter
IART vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 59.8% return, outperforming this stock by 110.7%
IART vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 116.4% return, outperforming this stock by 183.7%
Price to Sales
ForIART every $1 of sales, investors are willing to pay $1.1, whereas for Boston Scientific Corp., the investors are paying $8.2 for every $1 of sales.

Integra Lifesciences Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$1.5B	↑ 23.92%
Net Income	$60.8M	↓ 6.09%
Net Profit Margin	4.13%	↓ 1.32%

	FY19	Y/Y Change
Revenue	$1.5B	↑ 3.06%
Net Income	$50.2M	↓ 17.43%
Net Profit Margin	3.31%	↓ 0.82%

	FY20	Y/Y Change
Revenue	$1.4B	↓ 9.6%
Net Income	$133.9M	↑ 166.71%
Net Profit Margin	9.76%	↑ 6.45%

	FY21	Y/Y Change
Revenue	$1.5B	↑ 12.43%
Net Income	$169.1M	↑ 26.28%
Net Profit Margin	10.96%	↑ 1.2%

	FY22	Y/Y Change
Revenue	$1.6B	↑ 0.99%
Net Income	$180.6M	↑ 6.79%
Net Profit Margin	11.59%	↑ 0.63%

	FY23	Y/Y Change
Revenue	$1.5B	↓ 1.03%
Net Income	$67.7M	↓ 62.48%
Net Profit Margin	4.39%	↓ 7.2%

	Q2 FY23	Q/Q Change
Revenue	$381.3M	↑ 0.11%
Net Income	$4.2M	↓ 82.73%
Net Profit Margin	1.1%	↓ 5.26%

	Q3 FY23	Q/Q Change
Revenue	$382.4M	↑ 0.3%
Net Income	$19.5M	↑ 365.99%
Net Profit Margin	5.1%	↑ 4.0%

	Q4 FY23	Q/Q Change
Revenue	$397.0M	↑ 3.82%
Net Income	$19.8M	↑ 1.73%
Net Profit Margin	5.0%	↓ 0.1%

	Q1 FY24	Q/Q Change
Revenue	$368.9M	↓ 7.09%
Net Income	$-3.3M	↓ 116.54%
Net Profit Margin	-0.89%	↓ 5.89%

	Q2 FY24	Q/Q Change
Revenue	$418.2M	↑ 13.37%
Net Income	$-12.4M	↑ 277.99%
Net Profit Margin	-2.97%	↓ 2.08%

	Q3 FY24	Q/Q Change
Revenue	$380.8M	↓ 8.93%
Net Income	$-10.7M	↓ 13.76%
Net Profit Margin	-2.81%	↑ 0.16%

	FY18	Y/Y Change
Profit	$900.9M	↑ 19.69%

	FY19	Y/Y Change
Profit	$952.9M	↑ 5.76%

	FY20	Y/Y Change
Profit	$851.0M	↓ 10.69%

	FY21	Y/Y Change
Profit	$944.6M	↑ 11.0%

	FY22	Y/Y Change
Profit	$970.3M	↑ 2.72%

	FY23	Y/Y Change
Profit	$888.4M	↓ 8.44%

	Q2 FY23	Q/Q Change
Profit	$207.0M	↓ 11.1%

	Q3 FY23	Q/Q Change
Profit	$218.3M	↑ 5.47%

	Q4 FY23	Q/Q Change
Profit	$234.0M	↑ 7.16%

	Q1 FY24	Q/Q Change
Profit	$206.8M	↓ 11.6%

	Q2 FY24	Q/Q Change
Profit	$232.5M	↑ 12.39%

	Q3 FY24	Q/Q Change
Profit	$200.2M	↓ 13.87%

	FY18	Y/Y Change
Operating Cash Flow	$199.7M	↑ 74.33%
Investing Cash Flow	$-49.7M	↓ 95.93%
Financing Cash Flow	$-180.9M	↓ 115.47%

	FY19	Y/Y Change
Operating Cash Flow	$373.7M	↑ 87.14%
Investing Cash Flow	$-162.7M	↑ 227.27%
Financing Cash Flow	$64.5M	↓ 135.64%

	FY20	Y/Y Change
Operating Cash Flow	$203.8M	↓ 45.45%
Investing Cash Flow	$-68.1M	↓ 58.15%
Financing Cash Flow	$121.6M	↑ 88.68%

	FY21	Y/Y Change
Operating Cash Flow	$312.4M	↑ 53.28%
Investing Cash Flow	$-161.4M	↑ 137.16%
Financing Cash Flow	$-98.2M	↓ 180.76%

	FY22	Y/Y Change
Operating Cash Flow	$264.5M	↓ 15.35%
Investing Cash Flow	$-58.6M	↓ 63.71%
Financing Cash Flow	$-252.0M	↑ 156.5%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$28.3M	↑ 8.12%
Investing Cash Flow	$-15.5M	↑ 13.46%
Financing Cash Flow	$-10.7M	↓ 93.43%

Integra Lifesciences Technicals Summary

Sell

Neutral

Buy

Integra Lifesciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Integra Lifesciences Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Integra Lifesciences Holdings Corp	-5.22%	-26.92%	-51.11%	-68.02%	-63.3%
Stryker Corporation	-6.55%	7.53%	22.55%	38.08%	71.54%
Boston Scientific Corp.	-2.79%	15.96%	59.12%	110.98%	96.7%
Edwards Lifesciences Corp.	6.29%	-17.03%	-1.35%	-41.48%	-5.43%
Abbott Laboratories	-2.58%	8.48%	4.77%	-17.81%	30.77%
Medtronic Plc	-4.38%	-0.01%	-1.09%	-20.04%	-28.85%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Integra Lifesciences Holdings Corp	83.17	NA	0.73	2.45	0.0	0.03	NA	19.73
Stryker Corporation	38.32	38.32	2.51	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	73.27	73.27	1.61	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.88	28.88	6.79	2.55	0.19	0.11	NA	16.18
Abbott Laboratories	34.17	34.17	2.17	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.46	24.46	1.46	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Integra Lifesciences Holdings Corp	Buy	$1.7B	-63.3%	83.17	-0.42%
Stryker Corporation	Buy	$136.1B	71.54%	38.32	16.34%
Boston Scientific Corp.	Buy	$130.7B	96.7%	73.27	11.26%
Edwards Lifesciences Corp.	Buy	$44.1B	-5.43%	28.88	65.86%
Abbott Laboratories	Buy	$195.0B	30.77%	34.17	13.99%
Medtronic Plc	Buy	$102.6B	-28.85%	24.46	12.06%

About Integra Lifesciences

integra lifesciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. in the united states, integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. founded in 1989 integra is headquartered in plainsboro, new jersey and has over 3,500 employees worldwide. integra's common stock is li

Organization	Integra Lifesciences
Employees	3946
CEO	Dr. Stuart M. Essig Ph.D.
Industry	Health Technology

Management People of Integra Lifesciences

Name	Title
Dr. Stuart M. Essig Ph.D.	Executive Chairman
Mr. Jan De Witte	President, CEO & Director
Ms. Lea Daniels Knight	Executive VP & CFO
Mr. Jeffrey A. Mosebrook	Senior VP of Finance & Principal Accounting Officer
Mr. Eric Ian Schwartz J.D.	Executive VP, Chief Legal Officer & Secretary
Mr. Robert T. Davis Jr.	Executive VP & President of Tissue Technologies
Mr. Michael J. McBreen	Executive VP & President of Codman Specialty Surgical
Mr. Stephen Leonard	Corporate VP of Global Operations & Supply Chain
Laurene Isip	Vice President of Global Corporate Communications & Public Relations
Ms. Ruth L. Fleming	Vice President of Global Marketing

Important FAQs about investing in Integra Lifesciences from India :

What is Integra Lifesciences share price today?

Integra Lifesciences share price today stands at $21.80, Open: $21.48 ; Previous Close: $21.71 ; High: $22.28 ; Low: $21.31 ; 52 Week High: $45.42 ; 52 Week Low: $16.81. The stock opens at $21.48, after a previous close of $21.71. The stock reached a daily high of $22.28 and a low of $21.31, with a 52-week high of $45.42 and a 52-week low of $16.81.

Can Indians buy Integra Lifesciences shares?

Yes, Indians can invest in the Integra Lifesciences (IART) from India.

With INDmoney, you can buy Integra Lifesciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Integra Lifesciences at zero transaction cost.

How can I buy Integra Lifesciences shares from India?

It is very easy to buy Integra Lifesciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Integra Lifesciences be purchased?

Yes, you can buy fractional shares of Integra Lifesciences with INDmoney app.

What are the documents required to start investing in Integra Lifesciences stocks?

To start investing in Integra Lifesciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.